ThomasAGardnerMD

PubMed

• Sourcing faecal pollution: a combination of library-dependent and library-independent methods to identify human faecal pollution in non-sewered catchments.
  Ahmed, W., Stewart, J., Gardner, T., Powell, D., Brooks, P., Sullivan, D., Tindale, N.> ;Water Res. 2007 Aug
• Source apportionment of heavy metals and ionic contaminants in rainwater tanks in a subtropical urban area in Australia.
  Huston, R., Chan, Y. C., Chapman, H., Gardner, T., Shaw, G.> ;Water Res. 2012 Mar 15
• 33 citations
  Proptosis as the Initial Presentation of Fungal Sinusitis in Immunocompetent Patients
  Jeffrey S. Heier, Thomas A. Gardner, Michael J. Haves, Keith A. McGuire, Walton Wt, Jonathan Stock> ;Ophthalmology. 1995 May 1
• 11 citations
  Treatment of dysthyroid myopathy with adjustable suture recession.
  Thomas A. Gardner, John S. Kennerdell> ;Ophthalmic Surgery. 1990 Jul 1
• 29 citations
  Treatment of dysthyroid lower lid retraction with autogenous tarsus transplants.
  Thomas A. Gardner, John S. Kennerdell, George F. Buerger> ;Ophthalmic Plastic and Reconstructive Surgery. 1992 Jan 1
• Diagnostic flexible peritoneoscopy: assessment of the contralateral internal inguinal ring during unilateral herniorrhaphy.
  Gardner, T. A., Ostad, M., Mininberg, D. T.> ;J Pediatr Surg. 1998 Oct
• Microfocal prostate cancer: biopsy cancer volume does not predict actual tumour volume.
  Gardner, T. A., Lemer, M. L., Schlegel, P. N., Waldbaum, R. S., Vaughan, E. D., Steckel, J.> ;Br J Urol. 1998 Jun
• In vitro fertilization improves pregnancy rates for sperm obtained by rectal probe ejaculation.
  Matthews, G. J., Gardner, T. A., Eid, J. F.> ;J Urol. 1996 Jun
• Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary.
  Gorlick, R., Anderson, P., Andrulis, I., Arndt, C., Beardsley, G. P., Bernstein, M., Bridge, J., Cheung, N. K., Dome, J. S., Ebb, D., Gardner, T., Gebhardt, M., Grier,...> ;Clin Cancer Res. 2003 Nov 15
• Flexible transinguinal laparoscopy to assess the contralateral ring in pediatric inguinal hernias.
  Pavlovich, C. P., Gmyrek, G. A., Gardner, T. A., Poppas, D. P., Mininberg, D. T.> ;Tech Urol. 1998 Sep
• Sixth nerve palsy as the initial presenting sign of metastatic prostate cancer. A case report and review of the literature.
  O'Boyle, J. E., Gardner, T. A., Oliva, A., Enzenauer, R. W.> ;J Clin Neuroophthalmol. 1992 Sep
• Osteocalcin-directed gene therapy for prostate-cancer bone metastasis.
  Koeneman, K. S., Kao, C., Ko, S. C., Yang, L., Wada, Y., Kallmes, D. F., Gillenwater, J. Y., Zhau, H. E., Chung, L. W., Gardner, T. A.> ;World J Urol. 2000 Apr
• Serum-free recombinant production of adenovirus using a hollow fiber capillary system.
  Gardner, T. A., Ko, S. C., Yang, L., Cadwell, J. J., Chung, L. W., Kao, C.> ;Biotechniques. 2001 Feb
• HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation.
  Jung, C., Kim, R. S., Zhang, H., Lee, S. J., Sheng, H., Loehrer, P. J., Gardner, T. A., Jeng, M. H., Kao, C.> ;Br J Cancer. 2005 Jun 20
• Volvulus of the ileal conduit: a late complication.
  Gardner, T. A., Poppas, D. P., Wei, J. T., Blaivas, J. G.> ;J Urol. 1994 Sep
• Surgical and postoperative factors affecting length of hospital stay after radical prostatectomy.
  Gardner, T. A., Bissonette, E. A., Petroni, G. R., McClain, R., Sokoloff, M. H., Theodorescu, D.> ;Cancer. 2000 Jul 15
• Evaluation of hydrogel tissue sealant in porcine laparoscopic partial-nephrectomy model.
  Bernie, J. E., Ng, J., Bargman, V., Gardner, T., Cheng, L., Sundaram, C. P.> ;J Endourol. 2005 Nov
• Drug-resistant human bladder-cancer cells are more sensitive to adenovirus-mediated wild-type p53 gene therapy compared to drug-sensitive cells.
  Shirakawa, T., Sasaki, R., Gardner, T. A., Kao, C., Zhang, Z. J., Sugimura, K., Matsuo, M., Kamidono, S., Gotoh, A.> ;Int J Cancer. 2001 Oct 15
• Early catheter removal after radical retropubic prostatectomy: long-term followup.
  Koch, M. O., Nayee, A. H., Sloan, J., Gardner, T., Wahle, G. R., Bihrle, R., Foster, R. S.> ;J Urol. 2003 Jun
• Enhanced combined tumor-specific oncolysis and suicide gene therapy for prostate cancer using M6 promoter.
  Ahn, M., Lee, S. J., Li, X., Jiménez, J. A., Zhang, Y. P., Bae, K. H., Mohammadi, Y., Kao, C., Gardner, T. A.> ;Cancer Gene Ther. 2009 Jan
• p53 adenoviral vector (Ad-CMV-p53) induced prostatic growth inhibition of primary cultures of human prostate and an experimental rat model.
  Shirakawa, T., Gotoh, A., Gardner, T. A., Kao, C., Zhang, Z. J., Matsubara, S., Wada, Y., Hinata, N., Fujisawa, M., Hanioka, K., Matsuo, M., Kamidono, S.> ;J Gene Med. 2001 Feb 24
• Tissue-specific promoters in gene therapy for the treatment of prostate cancer.
  Shirakawa, T., Gotoh, A., Wada, Y., Kamidono, S., Ko, S. C., Kao, C., Gardner, T. A., Chung, L. W.> ;Mol Urol. 2000
• Chemogene therapy: osteocalcin promoter-based suicide gene therapy in combination with methotrexate in a murine osteosarcoma model.
  Cheon, J., Ko, S. C., Gardner, T. A., Shirakawa, T., Gotoh, A., Kao, C., Chung, L. W.> ;Cancer Gene Ther. 1997 Nov 01
• Cytotoxicity of adenoviral-mediated cytosine deaminase plus 5-fluorocytosine gene therapy is superior to thymidine kinase plus acyclovir in a human renal cell carcinom...
  Shirakawa, T., Gardner, T. A., Ko, S. C., Bander, N., Woo, S., Gotoh, A., Kamidono, S., Chung, L. W., Kao, C.> ;J Urol. 1999 Sep
• In vivo suppression of osteosarcoma pulmonary metastasis with intravenous osteocalcin promoter-based toxic gene therapy.
  Shirakawa, T., Ko, S. C., Gardner, T. A., Cheon, J., Miyamoto, T., Gotoh, A., Chung, L. W., Kao, C.> ;Cancer Gene Ther. 1998 Sep 01
• Join now to see all